Concepedia

Leigh Ervin

LE

Statistics

Publications

1

Citations

22

H-Index

1

Active since

2017

Affiliations

Innocrin Pharmaceuticals (United States)(Current)

Leigh Ervin is an author at Innocrin Pharmaceuticals (United States) specializing in oncology pharmacology, medicine, and endocrine pharmacotherapy.

Publications per year

2017–2017

1

Publications

1

Phase (Ph) 2 stage 1 clinical activity of seviteronel, a selective CYP17-lyase and androgen receptor (AR) inhibitor, in women with advanced AR+ triple-negative breast cancer (TNBC) or estrogen receptor (ER)+ BC: CLARITY-01.

Ayca Gucalp, Michael A. Danso, Anthony Elias et al. · Journal of Clinical Oncology · 2017 · 22 citations

, , +8

1–1 of 1